Sean D McAllister
Overview
Explore the profile of Sean D McAllister including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
926
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang S, Ice R, Chen M, Sidorov M, Woo R, Rodriguez-Brotons A, et al.
Mol Cancer Ther
. 2023 Jul;
22(9):1100-1111.
PMID: 37440705
As a result of tumor heterogeneity and solid cancers harboring multiple molecular defects, precision medicine platforms in oncology are most effective when both genetic and pharmacologic determinants of a tumor...
2.
Udalov A, Kumar L, Gaudette A, Zhang R, Salomao J, Saigal S, et al.
Methods Protoc
. 2023 May;
6(3).
PMID: 37218906
The longitudinal monitoring of patient circulating tumor DNA (ctDNA) provides a powerful method for tracking the progression, remission, and recurrence of several types of cancer. Often, clinical and research approaches...
3.
Chen M, Jian D, Sidorov M, Woo R, Kim A, Stone D, et al.
J Pers Med
. 2022 Dec;
12(11).
PMID: 36579573
We describe our institutional experience of developing a liquid biopsy approach using circulating tumor DNA (ctDNA) analysis for personalized medicine in cancer patients, focusing on the hurdles encountered during the...
4.
Soroceanu L, Singer E, Dighe P, Sidorov M, Limbad C, Rodriquez-Brotons A, et al.
Neurooncol Adv
. 2022 Mar;
4(1):vdac019.
PMID: 35356807
Background: Cannabidiol (CBD), a nonpsychoactive cannabinoid with a low toxicity profile, has been shown to produce antitumor activity across cancers in part through selective production of reactive oxygen species (ROS)...
5.
McAllister S, Abood M, Califano J, Guzman M
J Natl Cancer Inst Monogr
. 2021 Dec;
2021(58):99-106.
PMID: 34850900
Plant-based, synthetic, and endogenous cannabinoids have been shown to control a diverse array of biological processes, including regulation of cell fate across cancers. Their promise as broad-based antitumor agents in...
6.
Desprez P, Murase R, Limbad C, Woo R, Adrados I, Weitenthaler K, et al.
Cannabis Cannabinoid Res
. 2021 Apr;
6(2):148-155.
PMID: 33912679
We previously reported that cannabidiol (CBD), a cannabinoid with a low toxicity profile, downregulated the expression of the prometastatic gene inhibitor of DNA binding 1 () in cancer cells, leading...
7.
Ice R, Chen M, Sidorov M, Le Ho T, Woo R, Rodriguez-Brotons A, et al.
Br J Cancer
. 2019 Dec;
122(5):648-657.
PMID: 31857724
Background: Patient-derived xenograft (PDX) mouse tumour models can predict response to therapy in patients. Predictions made from PDX cultures (PDXC) would allow for more rapid and comprehensive evaluation of potential...
8.
Kirberger S, Ycas P, Johnson J, Chen C, Ciccone M, Woo R, et al.
Org Biomol Chem
. 2019 Feb;
17(7):2020-2027.
PMID: 30706071
Bromodomain and PHD finger containing protein transcription factor (BPTF) is an epigenetic protein involved in chromatin remodelling and is a potential anticancer target. The BPTF bromodomain has one reported small...
9.
Murase R, Sumida T, Kawamura R, Onishi-Ishikawa A, Hamakawa H, McAllister S, et al.
Cancer Lett
. 2016 Apr;
377(1):11-6.
PMID: 27087608
Salivary gland cancer (SGC) represents the most common malignancy in the head and neck region, and often metastasizes to the lungs. The helix-loop-helix ID1 protein has been shown to control...
10.
McAllister S, Soroceanu L, Desprez P
J Neuroimmune Pharmacol
. 2015 Apr;
10(2):255-67.
PMID: 25916739
As a therapeutic agent, most people are familiar with the palliative effects of the primary psychoactive constituent of Cannabis sativa (CS), Δ(9)-tetrahydrocannabinol (THC), a molecule active at both the cannabinoid...